Clinical Profile and Treatment of Multisystem Inflammatory Syndrome in Children (MIS-C) Linked to COVID-19 at Tertiary Care Centre in Western India
Asian Journal of Research in Infectious Diseases,
Aims: To assess the clinical presentation and therapeutic interventions administered to patients suffering from MIS-C in a tertiary centre in Western India.
Study Design: This is a cross sectional observational study.
Place and Duration of Study: Department of Pediatrics at Rajiv Gandhi Medical College, Chhatrapati Shivaji Maharaj Hospital, Thane, Maharashtra. It was conducted from September 2021-September 2022.
Methodology: Patients were clinically diagnosed as MIS-C based on the the Centers for Disease Control and Prevention (CDC) guidelines and retrospective analysis was carried out by reviewing medical records and complementary investigations.
Results: There were 36 children in total, 21 female (58.3%) and 15 males (41.7%) with ages ranging from less than 1 year to 18 years with mean age of 7.2 years. The symptoms were classified based on the organ system involved. Fever was present in most of the patients and Gastrointestinal symptoms in 18 (50%) were the most common followed by respiratory and Central Nervous System symptoms. Investigations revealed that White Blood Cell (WBC) count was predominantly normal in 77.8 %, with lymphocytopenia in 77.8% and reduced Hemoglobin (80.6 %). Inflammatory markers such as D-dimer, Erythrocyte sedimentation rate and serum Ferritin were raised in 94%, 88.9%, 86.1% respectively. Most of the patients 34 (94%), were treated with Intravenous steroids. IV immunoglobulin was given in 29 (80.6%). Out of the total 36 patients, there were 2 deaths.
Conclusion: Although SARS-CoV-2 infection is less severe in children than in adults, some pediatric patients may present with severe symptoms requiring intensive care. This case series of patients with MIS-C post COVID-19 identified patterns of clinical presentation and organ system involvement. Most were treated and responded to steroids and immunoglobulins.
- Multisystemic Inflammatory Syndrome in Children9 (MIS-C)
- kawasaki disease
How to Cite
Gruber CN, Patel RS,Trachtman R et al.Mapping systemic inflammation and antibody responses in Multisystem Inflammatory Syndrome in Children (MIS-C). Cell. 2020;183(4):982-995e14.
Hoste L, Van Paemel R, Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: A systematic review. Eur J Pediatr. 2021; 180(7):2019-2034.
Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 infection: Review of clinical presentation, hypothetical pathogenesis, and proposed management. Children (Basel). 2020;7(7):69.
Pediatric Covid 19 Field training, Government of Maharashtra Taskforce.
Feldstein LR, Rose EB, Horwitz SM, et al; Overcoming COVID-19 investigators; CDC COVID-19 response team. Multisystem inflammatory syndrome in US children and adolescents. N Engl J Med. 2020;383(4): 334-346.
Dufort EM, Koumans EH, Chow EJ, et al; New York state and centers for disease control and prevention multisystem inflammatory syndrome in children investigation team. Multisystem inflammatory syndrome in children in New York state. N Engl J Med. 2020;383(4): 347-358.
Swann OV, Holden KA, Turtle L, et al; ISARIC4C investigators. clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: Prospective multicentre observational cohort study. BMJ. 2020;370:m3249.
Fernandes DM, Oliveira CR, Guerguis S, et al; Tri-state pediatric COVID-19 research consortium. SARS-CoV-2 clinical syndromes and predictors of disease severity in hospitalized children and youth. J Pediatr; 2020.
Feldstein LR, Tenforde MW, Friedman KG, et al. Characteristics and outcomes of US children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) compared with severe acute COVID-19. JAMA. 2021;325(11):1074-1087.
Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145: e20200702.
Guidance - Paediatric multisystem inflammatory syndrome temporally associated with COVID-19. RCPCH.
Multisystem inflammatory syndrome in children and adolescents with COVID-19.
HAN Archive - 00432 | Health Alert Network (HAN); 2020.
Kids with Kawasaki disease symptoms possibly linked to COVID-19; Coronavirus infection leading to critical illness in children remains very infrequent. Am Heart Assoc.
Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607–8.
Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324(3):259–269.
Ramcharan T, Nolan O, Lai CY, Prabhu N, Krishnamurthy R, Richter AG, et al. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac features, management and short-term outcomes at a UK tertiary paediatric hospital. Pediatr Cardiol. 2020;41(7):1391-1401.
Davies P, Evans C, Kanthimathinathan HK, Lillie J, Brierley J, Waters G, et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: A multicentre observational study. Lancet Child Adolesc Health. 2020 ;4(9):669-677.
Wood LE, Tulloh RMR. Kawasaki disease in children. Heart Br Card Soc. 2009;95:787–92.
Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciufreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: An observational cohort study. Lancet. 2020;395:1771–8.
Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, Ross CE, McKiernan CA, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020;174(9):868-873.
Swann OV, Holden KA, Turtle L, Pollock L, Fairfeld CJ, Drake TM, et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in the United Kingdom: Prospective multicentre observational cohort study. BMJ. British Medical Journal Publishing Group; 2020.
Sperotto F, Friedman KG, Son MBF, VanderPluym CJ, Newburger JW, Dionne A. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: A comprehensive review and proposed clinical approach. Eur J Pediatr. 2021;180(2):307-322.
Buchdahl R, Levin M, Wilkins B, Gould J, Jafe P, Matthew DJ, et al. Toxic shock syndrome. Arch Dis Child. 1985;60:563–7.
Rostad CA, Chahroudi A, Mantus G, Lapp SA, Teherani M, Macoy L, et al. Quantitative SARS-CoV-2 serology in children with Multisystem Inflammatory Syndrome (MIS-C). Pediatrics; 146(6):1-29.e2020 018242.
Abstract View: 118 times
PDF Download: 30 times